Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Med ; 12(13)2023 Jun 22.
Article in English | MEDLINE | ID: mdl-37445249

ABSTRACT

Human-adipose-tissue-derived mesenchymal stromal cells (AD-MSCs) are currently being tested as autologous-cell-based therapies for use in tissue healing and regeneration. Recent studies have also demonstrated that AD-MSC-derived exosomes contribute to tissue repair and peripheral nerve regeneration. Subcutaneous abdominal adipose tissue (AAT) is divided into two layers: the superficial layer (sAAT) and the deep layer (dAAT). However, it is unclear whether there are particular characteristics of each layer in terms of AD-MSC regenerative potential. Using AD-MSCs purified and characterized from three abdominoplasties, we compared their secretomes and exosome functions to identify which layer may be most suitable as a source for cell therapy. Phenotypical analysis of the AD-MSCs containing stromal vascular fraction did not reveal any difference between the two layers. The AD-MSC secretomes showed a very similar pattern of cytokine content and both layers were able to release exosomes with identical characteristics. However, compared to the secretome, the released exosomes showed better biological properties. Interestingly, dAAT exosomes appeared to be more effective on neuromodulation, whereas neither sAAT nor dAAT-derived exosomes had significant effects on endothelial function. It thus appears that AD-MSC-derived exosomes from the two abdominal adipose tissue layers possess different features for cell therapy.

2.
Transbound Emerg Dis ; 69(3): 1256-1273, 2022 May.
Article in English | MEDLINE | ID: mdl-33787076

ABSTRACT

A number of owner practices among the pet dog and cat population can influence the dynamics of directly transmitted infectious dog and cat diseases, including zoonotic ones. To better depict these management practices, which include pet traveling, contact rates with other companion animals and their medical monitoring (which herein includes prevention aspects), we surveyed 2,122 dog- and/or cat-owning French households through an anonymous online questionnaire. Trips with dogs within the European Union (EU) were frequent, while cats travelled less frequently within the EU and both cats and dogs travelled less frequently outside the EU. Recurrent illegal trips with dogs and cats (non-compliant with regulatory measures) were observed in a context of non-systematic pet border controls. We found that a large proportion of dogs are taken for walks in metropolitan France, with frequent intraspecific contacts (1.4 contacts/day on average), but only a minority (1.4%) of dogs were allowed to roam freely. On the other hand, 59.7% of cat owners allowed their cats to roam freely. We classified pet owners according to different profiles, some of which may be considered 'at risk' for directly transmitted infectious pet diseases. Indeed, one dog owner profile and one cat owner profile depict 'spreaders' of pet diseases (high connectivity with other individuals, little medical monitoring but no traveling) and another dog owner profile describes a potential 'introducer' and 'spreader' of pet diseases (foreign travel, high connectivity with other individuals, and intermediate medical monitoring). While these 'at risk' profiles represent only a minority of French pet owners, they should be better characterized to reinforce targeted prevention designed to minimize the risk of (re)introduction and (re)emergence of directly transmitted infectious dog and cat diseases in France, especially when considering zoonoses with a significant potential impact, such as rabies.


Subject(s)
Cat Diseases , Communicable Diseases , Dog Diseases , Animals , Cat Diseases/epidemiology , Cat Diseases/prevention & control , Cats , Communicable Diseases/veterinary , Dog Diseases/epidemiology , Dog Diseases/prevention & control , Dogs , Pets , Surveys and Questionnaires , Zoonoses/epidemiology , Zoonoses/prevention & control
4.
J Am Acad Dermatol ; 83(6): 1759-1763, 2020 12.
Article in English | MEDLINE | ID: mdl-32244015
5.
Auris Nasus Larynx ; 43(1): 105-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26142980

ABSTRACT

A 61-year-old man with obstructive sleep apnea syndrome and normal BMI complained of dyspnea. Nasofibroscopy revealed a global and major oedema of the glottis and supraglottis and also a paralysis of the left vocal fold. CT-scan pointed out a spontaneous hyperdensity of the left arytenoid cartilage. A tracheostomy was performed. Clinical examination revealed large hands and macroglossy with high IGF1 rate. MRI confirmed a supracentimetric pituitary adenoma. To our knowledge, this is the first description of a case of acute respiratory distress due to unilateral larynx paralysis leading to acromegaly diagnosis. This is due to submucosal hypertrophy and vocal cord immobility.


Subject(s)
Acromegaly/diagnosis , Adenoma/diagnosis , Airway Obstruction/etiology , Dyspnea/etiology , Edema/diagnosis , Growth Hormone-Secreting Pituitary Adenoma/diagnosis , Laryngostenosis/diagnosis , Vocal Cord Paralysis/diagnosis , Acromegaly/complications , Adenoma/complications , Airway Obstruction/surgery , Arytenoid Cartilage/diagnostic imaging , Edema/complications , Growth Hormone-Secreting Pituitary Adenoma/complications , Humans , Laryngoscopy , Laryngostenosis/complications , Laryngostenosis/surgery , Male , Middle Aged , Tomography, X-Ray Computed , Tracheostomy , Vocal Cord Paralysis/complications , Vocal Cord Paralysis/surgery
6.
Environ Sci Pollut Res Int ; 20(2): 708-22, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23208753

ABSTRACT

The Seine Estuary is well known to be widely contaminated by organic pollutants and especially by polycyclic aromatic hydrocarbons (PAHs). Fish are known to metabolize PAHs, leading to different toxic effects at both cellular and sub-cellular levels. In this work, we studied the relationships between the 7-ethoxyresorufin-O-deethylase (EROD) activity in the liver, the level of DNA strand breaks in blood cells and the concentration of PAH metabolites in the bile of the sentinel flatfish species Limanda limanda. Muscle and liver samples were analysed for parent PAH levels. Female and male dabs of two size classes (juveniles and adults) were collected by trawling in two sites with different degrees of pollution during March and September 2005 and 2006. Significant effects of sex, age, site and season were demonstrated on EROD activity and the level of strand breaks. Parent PAH concentrations in dabs did not allow discriminating of the two sampling sites. However, for PAH metabolites, significant differences were observed with sites and seasons. Dabs collected at the mouth of the estuary appeared to be the most impacted when looking at the results obtained with the three selected markers. The significant correlations observed between the level of PAH metabolites and the level of DNA lesions showed the importance of a combined analysis of chemical and biochemical markers to correctly assess the contribution of chemical contamination to the toxic effects measured in situ in fish.


Subject(s)
Cytochrome P-450 CYP1A1/metabolism , DNA Damage , Flatfishes/genetics , Flatfishes/metabolism , Polycyclic Aromatic Hydrocarbons/metabolism , Polycyclic Aromatic Hydrocarbons/toxicity , Water Pollution, Chemical/analysis , Animals , Bile/metabolism , Environmental Monitoring/methods , Estuaries , Female , France , Gas Chromatography-Mass Spectrometry , Liver/drug effects , Liver/metabolism , Male , Muscles/drug effects , Muscles/metabolism , Polycyclic Aromatic Hydrocarbons/analysis , Seasons
7.
Environ Sci Pollut Res Int ; 20(2): 690-707, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23247530

ABSTRACT

In this study, laboratory experiments were carried out in order to come to a better understanding of the fate of polycyclic aromatic hydrocarbons (PAHs) in the marine environment and especially on their bioaccumulation, biotransformation and genotoxic effects in fish. Juveniles of turbot (Scophthalmus maximus) were exposed to PAHs through different routes via (1) a mixture of dissolved PAHs, (2) a PAH-polluted sediment and (3) an oil fuel elutriate. Fish were exposed 4 days followed by a 6-day depuration period. In each experiment, PAH concentrations in the seawater of the tanks were analysed regularly by gas chromatography coupled with mass spectrometry. Muscle and liver samples were also analysed for parent PAH levels and PAH bioconcentration factors were calculated. Biotransformation was evaluated by measuring the levels of PAH metabolites in fish bile. Genotoxicity was assessed by the alkaline comet assay. Regardless of exposure route, the parent PAH concentrations in the liver and muscle showed a peak level 1 day after the beginning of the exposure, followed by a decrease up to the background level towards the end of the experiment, except for the exposure to dissolved PAHs for which levels were relatively low throughout the study. As a consequence, no bioaccumulation was observed in fish tissues at the end of the experiment. In contrast, regardless of exposure routes, a rapid production of biliary metabolites was observed throughout the whole exposure experiment. This was especially true for 1-hydroxypyrene, the major metabolite of pyrene. After 6 days of recovery in clean water, a significant decrease in the total metabolite concentrations occurred in bile. Fish exposed through either route displayed a significant increase in DNA strand breaks after 4 days of exposure, and significant correlations were observed between the level of biliary PAH metabolites and the level of DNA lesions in fish erythrocytes. Overall results indicate that exposure to either a mixture of dissolved PAHs, a PAH-contaminated sediment or a dispersed oil fuel elutriate leads to biotransformation and increase in DNA damage in fish. The quantification of PAH metabolites in bile and DNA damage in erythrocytes appear to be suitable for environmental monitoring of marine pollution either in the case of accidental oil spills or sediment contamination.


Subject(s)
DNA Damage , Flatfishes/metabolism , Polycyclic Aromatic Hydrocarbons/pharmacokinetics , Polycyclic Aromatic Hydrocarbons/toxicity , Water Pollutants, Chemical/pharmacokinetics , Water Pollutants, Chemical/toxicity , Animals , Bile/drug effects , Bile/metabolism , DNA Damage/drug effects , Flatfishes/genetics , Geologic Sediments , Liver/drug effects , Liver/metabolism , Muscles/drug effects , Muscles/metabolism , Mutagenicity Tests , Polycyclic Aromatic Hydrocarbons/administration & dosage , Pyrenes/metabolism , Water Pollutants, Chemical/administration & dosage
8.
Int J Biochem Mol Biol ; 2(1): 24-30, 2011.
Article in English | MEDLINE | ID: mdl-21968505

ABSTRACT

Nucleophosmin (NPM/B23) is a multifunctional nucleolar protein to which both tumor-suppressor and oncogenic functions have been attributed. NPM/B23 has a variety of binding partners including ribosomes, nucleic acids, the centrosome and tumor suppressors such as p53 and p19ARF. These disparate functions are likely due to its ability to oligomerize and display molecular chaperone activity. In this report we identify a single amino acid residue, Cys(21), of nucleophosmin as important for the oligomerization and chaperone activity. Mutation of Cys(21) to aromatic hydrophobic residues (e.g., Phe or Try), but not to a conserved polar residue (e.g., Ser) inhibited the pentameric oligomerization of NPM/B23. However, only Phe substitution of Cys(21) drastically inhibited NPM/B23 chaperone activity. Interestingly, expression of Cys21Phe mutant in MCF7 cells demonstrated that this mutant protein does not co-polymerize with endogenous wild-type NPM/B23 and acts as negative dominant by destabilizing the endogenous dimer, trimer oligomerization. Taken together, the results in this study identify Cys(21) as critical residue for NPM/B23 oligomerization and chaperone functions. In addition, Cys(21) mutant provide a strong link between the oligomerization and chaperone functions of NPM/B23.

9.
J Med Chem ; 53(7): 2814-24, 2010 Apr 08.
Article in English | MEDLINE | ID: mdl-20210346

ABSTRACT

This report describes the synthesis and preliminary biological characterization of 2 (ANG1007) and 3 (ANG1009), two new chemical entities under development for the treatment of primary and secondary brain cancers. 2 consists of three doxorubicin molecules conjugated to Angiopep-2, a 19-mer peptide that crosses the blood-brain barrier (BBB) by an LRP-1 receptor-mediated transcytosis mechanism. 3 has a similar structure, with the exception that three etoposide moieties are conjugated to Angiopep-2. Both agents killed cancer cell lines in vitro with similar IC(50) values and with apparently similar cytotoxic mechanisms as unconjugated doxorubicin and etoposide. 2 and 3 exhibited dramatically higher BBB influx rate constants than unconjugated doxorubicin and etoposide and pooled within brain parenchymal tissue. Passage through the BBB was similar in Mdr1a (-/-) and wild type mice. These results provide further evidence of the potential of this drug development platform in the isolation of novel therapeutics with increased brain penetration.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Brain/metabolism , Doxorubicin/analogs & derivatives , Doxorubicin/chemistry , Doxorubicin/metabolism , Etoposide/analogs & derivatives , Etoposide/chemistry , Etoposide/metabolism , Peptides/chemistry , Peptides/metabolism , ATP Binding Cassette Transporter, Subfamily B/deficiency , Amino Acid Sequence , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Biological Transport , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Brain/cytology , Brain/pathology , Brain Neoplasms/drug therapy , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Cell Cycle/drug effects , Cell Line, Tumor , Doxorubicin/pharmacology , Doxorubicin/therapeutic use , Etoposide/pharmacology , Etoposide/therapeutic use , Etoposide/toxicity , Female , Humans , Inhibitory Concentration 50 , Kinetics , Male , Mice , Peptides/pharmacology , Peptides/therapeutic use , Peptides/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...